🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The purpose of the study is to evaluate the safety and efficacy of GLASSIA ...
Status
Terminated
Location
Georgia Cancer Center
Start Date
2017-04-26
Trial ID
NCT02956122
Treatments Being Tested
Steroid is the treatment of choice in patients with severe alcoholic hepati...
Status
Terminated
Location
Chuncheon Sacred Heart hospital
Start Date
2015-07
Trial ID
NCT02442180
Treatments Being Tested
The purpose of this study is to evaluate the effect of low dose versus high...
Status
Completed
Location
Cedars Sinai Medical Center
Start Date
2010-09
Trial ID
NCT01559675
Treatments Being Tested
Transplant rejection occurs when a patient's body does not recognize the ne...
Status
Completed
Location
University of Wisconsin - Department of Medicine
Start Date
2003-11
Trial ID
NCT00078559
This research study is a Phase II clinical trial, which tests the safety an...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-01
Trial ID
NCT02176031
Treatments Being Tested
This study will evaluate whether conversion from cyclosporine, a calcineuri...
Status
Terminated
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00452361
The painful episode is the most common problem experienced by children with...
Status
Terminated
Location
Texas Childrens Hospital
Start Date
2005-12-01
Trial ID
NCT00263562
Treatments Being Tested
The purpose of this study was to assess whether a new drug, Nulojix® (belat...
Status
Terminated
Location
University of Alabama
Start Date
2011-09
Trial ID
NCT01436305
Treatments Being Tested
This multi-center center phase I/II study to establish the lowest possible ...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-06-05
Trial ID
NCT05123040
Treatments Being Tested